TITAN Group Has Expanded Its Suite of DEA Compliance Services to Include Veterinary RACE-Approved Online Continuing Education Courses Developed by Its Team of Former DEA Agents and Diversion Investigators

TITAN Group, a leading industry provider of DEA-compliance and controlled-substance anti-diversion solutions, is proud to announce the launch of its RACE-approved, online continuing education courses designed specifically for the veterinary community.

Available now, TITAN’s engaging, web-based courses are designed to keep veterinary professionals up-to-date on DEA requirements surrounding the handling of controlled substances, best practices for maintaining DEA compliance and proactive measures to protect against drug diversion.

With more than three decades of experience in DEA compliance, state regulatory compliance and drug-related criminal investigations, TITAN’s team of experts is trained to help veterinary practices and professionals reduce risk while shining a light on proper protocols for adhering to DEA compliance requirements. TITAN’s suite of controlled-substance compliance solutions have been implemented in veterinary facilities nationwide; ranging from private practices and emergency services to medical referral centers and veterinary supply chain distributors.

“Our DEA compliance courses were developed to meet an industry need,” said TITAN CMO, Sharon Teitelman. “Since the launch of TITAN Group in 2016, we have continued to receive feedback from clients and industry contacts noting a lack of education concerning proper protocols for controlled-substance compliance in the veterinary industry. We are excited to bring this new education product to market, to help meet this important need.”

According to a September 2018 survey conducted by American Journal of Public Health (AJPH) on United States veterinarians and their relationship to America’s opioid epidemic, substantial gaps in knowledge and education were reported as barriers to be overcome. Of the surveyed veterinarians, 64% indicated they had not completed continuing education on best practices for prescribing opioids since entering practice. Another 73% said their veterinary medical school training on opioid abuse or misuse was fair, poor or absent. In addition, the following continuing educational priorities were identified: opioid abuse prevention (81%); pain management guidelines (55%); how to engage electronic resources (54%), and improving PDMP guidelines and tutorials to help improve access and utilization (36%).

“For many veterinary professionals, the workplace is an ever-changing, ‘all-hands-on-deck’ environment,” added TITAN COO, Kelley Detweiler. “Along with meeting an industry need, our educational content is designed to provide easy access to DEA compliance requirements that will remain relevant to both independent professionals and larger companies.”

TITAN’s online veterinary continuing education courses kickoff with three DEA-compliance modules, and an additional seven more are scheduled to release by Q4 2019. All courses are available for purchase directly through Titan’s website.

“Far too many individuals gain access to addictive, prescription medications due to employee drug diversion in the workplace,” stated TITAN Founder and CEO, Jack Teitelman. “By offering veterinary professionals easy access to education concerning DEA compliance, we hope to reduce the number of diverted drugs hitting the streets and bridge learning gaps that exist throughout the veterinary community.”

Founded by retired DEA Supervisory Special Agent, Jack Teitelman, TITAN Group is a full-service regulatory compliance, drug security and anti-diversion solutions provider. Titan’s team of experts serve veterinary practices, clinics and other healthcare clients using more than three decades of law enforcement, security and private industry experience. TITAN’s services are designed to identify and mitigate risks via improved physical security, staff education, recordkeeping audits and operational assessments.

Share This